Notably, we observed a general downregulation of DNMT3A transcript as well as protein levels in biopsies and purified IECs from patients with IBD and also demonstrate that the genetic risk for IBD at the human DNMT3A locus is mediated by repression of DNMT3A mRNA levels. Here, DNMT3A is linked to inflammatory bowel disease.